Effectiveness of TENS on Fibromyalgia

TENS 对纤维肌痛的疗效

• 批准号: 8023139
• 负责人: KATHLEEN A SLUKA
• 金额: $ 16.24万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-01-17 至 2013-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8023139
• 关键词: American; Articular Range of Motion; Basic Science; Brain Stem; Brief Pain Inventory; Chronic; Clinical; Clinical Trials; Degenerative polyarthritis; Effectiveness; Electric Stimulation; Fatigue; Fibromyalgia; Frequencies; Fright; Future; Health Professional; Home environment; Individual; Intervention; Laboratories; Measures; Midbrain structure; Modality; Movement; Muscle; Musculoskeletal Pain; Neuraxis; Neurons; Nociception; Outcome; Outcome Measure; Pain; Pain Threshold; Pain management; Participant; Pathway interactions; Patients; Persons; Physical Function; Physiological; Physiology; Placebo Control; Placebos; Population; Postoperative Pain; Process; Quality of life; Questionnaires; Rest; Rheumatology; Sensory; Skin; Social Work; Spinal; Spinal Cord; Symptoms; Syndrome; Testing; Transcutaneous Electric Nerve Stimulation; Visual; Walking; Work; analog; chronic pain; college; daily functioning; design; diffuse noxious inhibitory control; effective therapy; foot; improved functioning; innovation; pain inhibition; patient population; pressure

DESCRIPTION (provided by applicant): Fibromyalgia is a chronic pain condition that is characterized by widespread pain. Pain associated with fibromyalgia interferes with daily function, work, and social activities resulting in a decreased quality of life. In addition people with fibromyalgia have a significant amount fatigue and a fear of movement. The cause of fibromyalgia is unknown, but people with fibromyalgia show enhanced excitability of pain neurons in central nervous system and reduced pain inhibition. One of the main treatments for patients with fibromyalgia must, therefore, focus on pain relief to allow the person to function more independently both at home and at work. Transcutaneous electrical nerve stimulation (TENS) is a modality used by health professionals that delivers electrical stimulation through the skin for pain control. Basic science studies, from the PIs laboratory, show that TENS activates descending pain inhibitory pathways to inhibit excitability of pain neurons. Thus, the ideal patient population for the treatment of TENS would be one in which there is enhanced central excitability and reduced inhibition; fibromyalgia is such a condition. Although TENS is effective for several pain conditions such as osteoarthritis, chronic musculoskeletal pain, and postoperative pain [5;20;39], its effectiveness in treatment of people with fibromyalgia is virtually unknown. Furthermore, there is a general thought among clinicians that since fibromyalgia pain is widespread, TENS would be ineffective in this population. Thus, TENS may decrease pain associated with fibromyalgia by increasing central inhibition and decreasing central excitability. This decrease in pain is expected to increase function and improve quality of life. We hypothesize that application of TENS to patients with fibromyalgia will reduce resting and movement-related pain and reduce central excitability by restoring diffuse noxious inhibitory controls (DNIC), and that this decrease in pain and/or central excitability will reduce fatigue and fear of movement, thereby improving function and quality of life. We will test this hypothesis through 3 Specific Aims. Aim #1: The primary aim of the study is to test the effectiveness of the long-term use of TENS on resting and movement-related pain in people with fibromyalgia with random assignment to three treatments: no treatment control, placebo TENS and active TENS. Aim #2: A secondary aim will test if pain reduction by TENS results in a concomitant decrease in fatigue and fear of movement, and an increase in function and quality of life. Aim #3 will determine if active TENS alters pain processing in people with fibromyalgia and if improvement in clinical symptoms correlates with normalization of pain processing physiology. This innovative study will be the first to examine the effectiveness of TENS in people with fibromyalgia using multiple outcomes including pain at rest and during movement, as well as function, fatigue, and quality of life in individuals with fibromyalgia. Using multiple measures will give us a better understanding of appropriate measures for future clinical trials of non-pharmacological treatments, and for treatment of pain in people with fibromyalgia.

描述（由申请人提供）：纤维肌痛是一种以广泛疼痛为特征的慢性疼痛状况。与纤维肌痛相关的疼痛会干扰日常功能，工作和社交活动，导致生活质量降低。此外，患有纤维肌痛的人也有很大的疲劳和对运动的恐惧。纤维肌痛的原因尚不清楚，但是纤维肌痛的人在中枢神经系统中表现出疼痛神经元的兴奋性增强，疼痛抑制减少。因此，对于纤维肌痛患者的主要治疗方法之一必须集中于缓解疼痛，以使该人在家里和工作中都能更独立地发挥作用。经牙性电神经刺激（TENS）是卫生专业人员使用的一种方式，可以通过皮肤进行电刺激以控制疼痛。来自PIS实验室的基础科学研究表明，TENS激活了降低疼痛抑制途径以抑制疼痛神经元的兴奋性。因此，用于治疗TEN的理想患者人群将是中心兴奋性增强和抑制作用的理想患者。纤维肌痛是一种情况。尽管TENS对几种疼痛疾病有效，例如骨关节炎，慢性肌肉骨骼疼痛和术后疼痛[5; 20; 39]，但其在治疗纤维肌痛患者方面的有效性实际上是未知的。此外，临床医生普遍认为，由于纤维肌痛疼痛是普遍的，因此在该人群中有十分无效。因此，TEN可以通过增加中心抑制和降低中心兴奋性来减轻与纤维肌痛相关的疼痛。疼痛的减少预计会增加功能并改善生活质量。我们假设在纤维肌痛患者中的应用将减轻静止和运动相关的疼痛，并通过恢复弥漫性有害抑制性控制（DNIC）来降低中心兴奋性，并且疼痛和/或中心兴奋性的减少将减少疲劳和对运动的恐惧，从而改善生活和生活质量和质量。我们将通过3个特定目标检验这一假设。目标＃1：该研究的主要目的是测试纤维肌痛的静息和运动相关疼痛的长期使用的有效性，并随机分配给三种治疗方法：没有治疗控制，安慰剂TENS和活跃的TENS。目标＃2：次要目标将测试是否减轻疼痛是否会导致疲劳和对运动的恐惧以及功能和生活质量的增加。 AIM＃3将确定主动数TENS是否会改变纤维肌痛患者的疼痛处理以及临床症状的改善是否与疼痛处理生理学的标准化相关。这项创新的研究将是第一个使用多种结果，包括在休息和运动期间以及功能，疲劳和纤维肌痛患者的功能，疲劳和生活质量，首次检查TEN在纤维肌痛中的有效性。使用多种措施将使我们更好地了解非药物治疗的未来临床试验以及治疗纤维肌痛患者疼痛的适当措施。

项目成果

Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia.

• DOI: 10.1016/j.pain.2013.07.043
• 发表时间: 2013-11
• 期刊: Pain
• 影响因子: 7.4
• 作者: Dailey DL;Rakel BA;Vance CGT;Liebano RE;Amrit AS;Bush HM;Lee KS;Lee JE;Sluka KA
• 通讯作者: Sluka KA